Population-based service mammography screening: the Icelandic experience

Código QR

Population-based service mammography screening: the Icelandic experience

Kristjan Sigurdsson,1,3 Elínborg Jóna Ólafsdóttir,21The Icelandic Cancer Detection Clinic, 2The Icelandic Cancer Registry, Icelandic Cancer Society, 3Faculty of Medicine, University of Iceland, Reykjavik, IcelandObjective: This study analyzes the efficacy...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sigurdsson K, &Oacute;lafsd&oacute;ttir EJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/8fb29323ab2c489690f46a1fe429c7d8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening
por: Nehmat Houssami, et al.
Publicado: (2017)

Association of p21 Ser31Arg and p53 Arg72Pro polymorphisms with lung cancer risk in CAPUA study
por: Pascual T, et al.
Publicado: (2012)

Update on biomarkers for the detection of lung cancer
por: Jantus-Lewintre E, et al.
Publicado: (2012)

Can population breast screening programs be leveraged to reduce the burden of breast cancer?
por: Nehmat Houssami
Publicado: (2021)

A “water”‐based educational intervention to increase the public's utilization of low‐dose computed tomography‐based lung‐cancer screening services
por: Bernard M. H. Law, et al.
Publicado: (2021)

Breast magnetic resonance imaging as a problem solving tool in women recalled at biennial screening mammography: A population-based study in the Netherlands
por: Jessie JJ. Gommers, et al.
Publicado: (2021)

Non-small cell lung cancer: the era of targeted therapy
por: Antonoff MB, et al.
Publicado: (2012)

Knowledge, Attitude and Practice Around Breast Cancer and Mammography Screening Among Jordanian Women
por: Al-Mousa DS, et al.
Publicado: (2020)

Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study
por: Tai-Jan Chiu, et al.
Publicado: (2021)

Targeting PD-1/PD-L1 in lung cancer: current perspectives
por: González-Cao M, et al.
Publicado: (2015)

MET overexpression and gene amplification in NSCLC: a clinical perspective
por: Landi L, et al.
Publicado: (2013)

Management of early breast cancer in older women: from screening to treatment
por: Elomrani F, et al.
Publicado: (2015)

Effectiveness of the Korean National Cancer Screening Program in reducing breast cancer mortality
por: Eunji Choi, et al.
Publicado: (2021)

Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry
por: Yash S. Huilgol, et al.
Publicado: (2021)

The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease
por: Francisco Beca, et al.
Publicado: (2021)

The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group
por: Marion Maetens, et al.
Publicado: (2017)

Clinical Preventive Services and Self-Management Practices Among Adult Cancer Survivors in the United States Over Time
por: Patricia A. Findley DrPH, MSW, et al.
Publicado: (2021)

Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
por: Michael Dougan, et al.
Publicado: (2021)

Correction: Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
Publicado: (2021)

Radiotherapy of early breast cancer in scleroderma patients: our experience with four cases and a short review of the literature
por: Kyrgias G, et al.
Publicado: (2012)

Breast Self-Examination Practice and Associated Factors Among Women Attending Family Planning Service in Modjo Public Health Facilities Southwest Ethiopia [Response To Letter]
por: Asmare Adella G
Publicado: (2021)

Novel evolutionary dynamics of small populations in breast cancer adjuvant and neoadjuvant therapy
por: Yael Artzy-Randrup, et al.
Publicado: (2021)

Treatment scheduling effects on the evolution of drug resistance in heterogeneous cancer cell populations
por: Gauri A. Patwardhan, et al.
Publicado: (2021)

Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study
por: Saemundur Rognvaldsson, et al.
Publicado: (2021)

Elevated preoperative serum cancer antigen 15.3 levels are associated with reduced disease-free survival: a single-institution experience
por: Alsaeed EF, et al.
Publicado: (2013)

Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience
por: Daniele Cattaneo, et al.
Publicado: (2021)

Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study
por: Mirian Brink, et al.
Publicado: (2021)

Antihypertensive treatments and risks of lung Cancer: a large population-based cohort study in Hong Kong
por: Jinhui Li, et al.
Publicado: (2021)

Risk of second primary malignancies in patients with follicular lymphoma: a population-based study in the Netherlands, 1989-2018
por: Manette A. W. Dinnessen, et al.
Publicado: (2021)

Risk of primary lung cancer after adjuvant radiotherapy in breast cancer—a large population-based study
por: Anna-Karin Wennstig, et al.
Publicado: (2021)

Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population
por: C. B. Westphalen, et al.
Publicado: (2021)

Second Primary Malignancies in Patients with Pancreatic Neuroendocrine Neoplasms: A Population-Based Study on Occurrence, Risk Factors, and Prognosis
por: Tulan Hu, et al.
Publicado: (2021)

Author Correction: Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population
por: C. B. Westphalen, et al.
Publicado: (2021)

Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA
por: Kun-Hsing Yu, et al.
Publicado: (2021)

Correction: Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids
Publicado: (2021)

Diagnosis of Breast Cancer Using Radiomics Models Built Based on Dynamic Contrast Enhanced MRI Combined With Mammography
por: You-Fan Zhao, et al.
Publicado: (2021)

B3 Lesions at Vacuum-Assisted Breast Biopsy under Ultrasound or Mammography Guidance: A Single-Center Experience on 3634 Consecutive Biopsies
por: Veronica Girardi, et al.
Publicado: (2021)

Breast cancer risk in a rapidly aging population: advances and approaches to study the aging tissue microenvironment
por: Greco SJ
Publicado: (2019)

Aged neutrophils form mitochondria-dependent vital NETs to promote breast cancer lung metastasis
por: Ke Wang, et al.
Publicado: (2021)

Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma
por: Stefan Nierkens, et al.
Publicado: (2021)